Key result
Statin therapy for primary prevention in octogenarians lacks conclusive evidence of mortality benefit and may be associated with adverse effects, necessitating a cautious clinical approach.
Why the study?
Does statin therapy reduce morbidity or mortality in octogenarians and nonagenarians?
Population
Older adults (specifically octogenarians and nonagenarians) with hypercholesterolemia
Design
Editorial
Authors
Loading...
This editorial argues that current evidence does not support aggressive statin therapy for primary prevention in octogenarians and nonagenarians, highlighting potential risks of hypocholesterolemia and adverse drug reactions.
Does statin therapy reduce morbidity or mortality in octogenarians and nonagenarians?
This editorial argues that current evidence does not support aggressive statin therapy for primary prevention in octogenarians and nonagenarians, highlighting potential risks of hypocholesterolemia and adverse drug reactions.
M.-M. G. Wilson (2005) conducted an editorial in Hypercholesterolemia. Statin therapy was evaluated. Statin therapy for primary prevention in octogenarians lacks conclusive evidence of mortality benefit and may be associated with adverse effects, necessitating a cautious clinical approach.